Health Dictionary

Overview

Osteolysis is the softening, absorption and destruction of bony tissue.

Causes

Common Causes

Causes by Organ System

Cardiovascular	No underlying causes
Chemical/Poisoning	Polyvinyl chloride
Dental	No underlying causes
Dermatologic	Haim-munk syndrome, Mycetoma, Psoriasis
Drug Side Effect	No underlying causes
Ear Nose Throat	Peridontal disease
Endocrine	Hyperparathyroidism
Environmental	No underlying causes
Gastroenterologic	No underlying causes
Genetic	Bonnet-dechaume-blanc syndrome, Gaucher disease, Haim-munk syndrome, Hajdu-cheney syndrome, Hutchinson-gilford progeria syndrome, Idiopathic multicentric osteolysis, Interleukin 1 receptor antagonist deficiency, Majeed syndrome, Systemic hyalinosis, Torg-winchester syndrome, Van bogaert-hozay syndrome
Hematologic	Gorham vanishing bone disease, Hairy cell leukaemia, Histiocytosis x, Sickle cell disease
Iatrogenic	Prosthetics
Infectious Disease	Cysts, Mycetoma, Peridontal disease, Secondary syphilis, Tertiary syphilis
Musculoskeletal/Orthopedic	Acroosteolysis, Adamantinoma, Aging, Bone tumors, Chondroblastoma, Chondromyxoid fibroma, Chronic inflammation, Cleidocranial dysplasia, Craniomandibular dermatodysostosis, Desmoplastic fibroma, Enchondroma, Enchondromatosis, Epithelioid hemangioendothelioma, Ewing sarcoma, Gorham vanishing bone disease, Hajdu-cheney syndrome, Idiopathic multicentric osteolysis, Myeloma, Osteosarcoma, Polyostotic fibrous dysplasia, Polyostotic osteolytic expansile dysplasia, Pyknodysostosis, Reiter syndrome, Subchondral stress fracture, Torg-winchester syndrome, Van bogaert-hozay syndrome
Neurologic	Bonnet-dechaume-blanc syndrome, Cleidocranial dysplasia, Craniomandibular dermatodysostosis, Hereditary sensory and autonomic neuropathy type 2, Neuroblastoma
Nutritional/Metabolic	No underlying causes
Obstetric/Gynecologic	No underlying causes
Oncologic	Adamantinoma, Bone tumors, Chondroblastoma, Chondromyxoid fibroma, Desmoplastic fibroma, Enchondroma, Enchondromatosis, Epithelioid hemangioendothelioma, Ewing sarcoma, Hairy cell leukaemia, Myeloma, Neuroblastoma, Osteosarcoma
Ophthalmologic	No underlying causes
Overdose/Toxicity	No underlying causes
Psychiatric	No underlying causes
Pulmonary	Sarcoidosis
Renal/Electrolyte	No underlying causes
Rheumatology/Immunology/Allergy	Arithritis, Polyostotic fibrous dysplasia, Polyostotic osteolytic expansile dysplasia, Psoriasis, Reiter syndrome, Sarcoidosis, Systemic hyalinosis, Systemic sclerosis
Sexual	Secondary syphilis, Tertiary syphilis
Trauma	Frostbite, Subchondral stress fracture
Urologic	No underlying causes
Miscellaneous	Aging, Chronic inflammation

Cause in Alphabetical Order

Differential Diagnosis

In alphabetical order. ^[1] ^[2]

Bone hemangioendothelioma
Central Chondroma
Chondromatosis
Hand-Schuller-Christian Disease
Eosinophillic bone granulation tumor
Extraosseous soft tissue tumor
Leukemia
Lymphogranuloma
Metastases
Multiple Myeloma
Osteolytic sarcoma
Syphillitic gumma

osteolysis must be differentiated from other causes of hypercalcaemia

Differential diagnosis of hyperparathyroidism on the basis of hypercalcemia
Disorder		Mechanism of hypercalcemia	Clinical features	Laboratory findings				Imaging & diagnostic modalities
Disorder		Mechanism of hypercalcemia	Clinical features	PTH	Calcium	Phosphate	Other findings	Imaging & diagnostic modalities
Hyperparathyroidism	Primary hyperparathyroidism	Increase in secretion of parathyroid hormone (PTH) from a primary process in parathyroid gland. Parathyroid hormone causes increase in serum calcium.	Usually asymptomatic Hypercalcemia detected on routine biochemical panel	↑	↑	↓/Normal	Normal/↑ calcitriol	Findings of bone resorption: X-ray Dual energy X-ray absorptiometry (DXA) Preoperative localization of hyperfunctioning parathyroid gland: Non-Invasive Tc-99m sestamibi scintigraphy Neck ultrasound 4D-CT SPECT(P-SPECT) PET MRI Invasive: Super sensitive venous sampling Selective arteriography Angiography Predicting post-operative success: Intraoperative parathyroid hormone monitoring
	Secondary hyperparathyroidism	Increase in secretion of parathyroid hormone (PTH) from a secondary process. Parathyroid hormone causes increase in serum calcium after long periods.	May present with history of: Chronic renal failure Vitamin D deficiency	↑	↓/Normal	↑	—
	Tertiary hyperparathyroidism	Continuous elevation of parathyroid hormone (PTH) even after successful treatment of the secondary cause of elevated parathyroid hormone. Parathyroid hormone causes increase in serum calcium.	Usually present with history of kidney transplant Usually hyperplasia of all four parathyroid glands	↑	↑	↑	—
Familial hypocalciuric hypercalcemia		This is a genetic disorder caused my mutation in calcium-sensing receptor gene.	A benign condition Does not require treatment	Normal/↑	Normal/↑	—	—	Urinary calcium/creatinine clearance ratio
Malignancy^[3]	Humoral hypercalcemia of malignancy^[4]^[5]^[6]	Tumor cells secretes parathyroid hormone-related protein (PTHrP) which has similar action as parathyroid hormone.	Most common cause of malignancy related hypercalcemia Usually present with solid tumors	—	↑	↓/Normal	↑ PTHrP Normal/↑ calcitriol	Chest X-ray CT scan MRI
	Osteolytic tumors	Multiple myeloma produces osteolysis of bones causing hypercalcemia. Osteolytic metasteses can cause bone resorption causing hypercalcemia.	Commonly present in multiple myeloma and breast cancer	↓	↑	—	—	DXA X-ray Mammography Ultrasound ESR Serum protein electrophoresis
	Production of calcitirol	Some tumors has ectopic activity of 1-alpha-hydroxylase leading to increased production of calcitriol. Calcitriol is active form of vitamin D and causes hypercalcemia.	Commonly present in lymphomas and in some ovarian germ cell tumors	—	↑	—	↑ Calcitriol	CT scan MRI
	Ectopic parathyroid hormone^[7]	Some tumors leads to ectopic production of parathyroid hormone.	In rare instances, small cell carcinoma of lung may produce hypercalcemia by this process	↑	↑	↓/Normal	Normal/↑ calcitriol	Chest X-ray CT scan MRI
Medication induced	Lithium^[8]	Lithium lowers urinary calcium and causes hypercalcemia. Lithium has been reported to cause an increase in parathyroid hormone and enlargement if parathyroid gland after weeks to months of therapy.	History of mood disorder	↑	↑	—	—	Lithium levels
Medication induced	Thiazide diuretics	Thiazide diuretics lowers urinary calcium excretion and causes hypercalcemia.	History of cardiac disorder Rarely causes hypercalcemia	—	↑	—	—	—
Nutritional	Milk-alkali syndrome	Hypercalcemia is be caused by high intake of calcium carbonate.	History of High milk intake Excess calcium intake for treating: Osteoporosis Dyspepsia May lead to metabolic alkalosis and renal insufficiency.	—	↑	—	—	Renal function tests
Nutritional	Vitamin D toxicity	Excess vitamin D causes increased absorption of calcium from intestine causing hypercalcemia.	History of: Excess intake vitamin D Excess milk fortified with vitamin D^[9] Topical application of vitamin D analogue calcipotriol^[10]	—	↑	—	↑ Vitamin D (calcidiol and/or calcitriol)	—
Granulomatous disease	Sarcoidosis^[11]	Hypercalcemia is causes by endogeous production of calcitriol by disease-activated macrophages.	History of: Cough Dyspnea Chest pain Tiredness or weakness Fever Weight loss	—	↑	—	↑ Calcitriol ↑ ACE levels	Chest X-ray Biopsy

References

↑ Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016
↑ Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:68 ISBN 140510368X
↑ Mirrakhimov AE (2015). “Hypercalcemia of Malignancy: An Update on Pathogenesis and Management”. N Am J Med Sci. 7 (11): 483–93. doi:10.4103/1947-2714.170600. PMC 4683803. PMID 26713296.
↑ Ratcliffe WA, Hutchesson AC, Bundred NJ, Ratcliffe JG (1992). “Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia”. Lancet. 339 (8786): 164–7. doi:10.1016/0140-6736(92)90220-W. PMID 1346019.
↑ Ikeda K, Ohno H, Hane M, Yokoi H, Okada M, Honma T, Yamada A, Tatsumi Y, Tanaka T, Saitoh T (1994). “Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma”. J. Clin. Endocrinol. Metab. 79 (5): 1322–7. doi:10.1210/jcem.79.5.7962324. PMID 7962324.
↑ Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF (2003). “Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers”. J. Clin. Endocrinol. Metab. 88 (4): 1603–9. doi:10.1210/jc.2002-020773. PMID 12679445.
↑ VanHouten JN, Yu N, Rimm D, Dotto J, Arnold A, Wysolmerski JJ, Udelsman R (2006). “Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene”. J. Clin. Endocrinol. Metab. 91 (2): 580–3. doi:10.1210/jc.2005-2095. PMID 16263810.
↑ Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S (1989). “Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume”. J. Clin. Endocrinol. Metab. 68 (3): 654–60. doi:10.1210/jcem-68-3-654. PMID 2918061.
↑ Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW (1992). “Hypervitaminosis D associated with drinking milk”. N. Engl. J. Med. 326 (18): 1173–7. doi:10.1056/NEJM199204303261801. PMID 1313547.
↑ Hoeck HC, Laurberg G, Laurberg P (1994). “Hypercalcaemic crisis after excessive topical use of a vitamin D derivative”. J. Intern. Med. 235 (3): 281–2. PMID 8120527.
↑ Dusso AS, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S, Slatopolsky E (1997). “gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses”. J. Clin. Endocrinol. Metab. 82 (7): 2222–32. doi:10.1210/jcem.82.7.4074. PMID 9215298.

Template:Diseases of the musculoskeletal system and connective tissue

Template:WikiDoc Sources

[1] Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016

[2] Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:68 ISBN 140510368X

[pmid26713296-3] Mirrakhimov AE (2015). “Hypercalcemia of Malignancy: An Update on Pathogenesis and Management”. N Am J Med Sci. 7 (11): 483–93. doi:10.4103/1947-2714.170600. PMC 4683803. PMID 26713296.

[pmid1346019-4] Ratcliffe WA, Hutchesson AC, Bundred NJ, Ratcliffe JG (1992). “Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia”. Lancet. 339 (8786): 164–7. doi:10.1016/0140-6736(92)90220-W. PMID 1346019.

[pmid7962324-5] Ikeda K, Ohno H, Hane M, Yokoi H, Okada M, Honma T, Yamada A, Tatsumi Y, Tanaka T, Saitoh T (1994). “Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma”. J. Clin. Endocrinol. Metab. 79 (5): 1322–7. doi:10.1210/jcem.79.5.7962324. PMID 7962324.

[pmid12679445-6] Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF (2003). “Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers”. J. Clin. Endocrinol. Metab. 88 (4): 1603–9. doi:10.1210/jc.2002-020773. PMID 12679445.

[pmid16263810-7] VanHouten JN, Yu N, Rimm D, Dotto J, Arnold A, Wysolmerski JJ, Udelsman R (2006). “Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene”. J. Clin. Endocrinol. Metab. 91 (2): 580–3. doi:10.1210/jc.2005-2095. PMID 16263810.

[pmid2918061-8] Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S (1989). “Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume”. J. Clin. Endocrinol. Metab. 68 (3): 654–60. doi:10.1210/jcem-68-3-654. PMID 2918061.

[pmid1313547-9] Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW (1992). “Hypervitaminosis D associated with drinking milk”. N. Engl. J. Med. 326 (18): 1173–7. doi:10.1056/NEJM199204303261801. PMID 1313547.

[pmid8120527-10] Hoeck HC, Laurberg G, Laurberg P (1994). “Hypercalcaemic crisis after excessive topical use of a vitamin D derivative”. J. Intern. Med. 235 (3): 281–2. PMID 8120527.

[pmid9215298-11] Dusso AS, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S, Slatopolsky E (1997). “gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses”. J. Clin. Endocrinol. Metab. 82 (7): 2222–32. doi:10.1210/jcem.82.7.4074. PMID 9215298.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]